NEW YORK (GenomeWeb News) – The Singapore Institute of Manufacturing Technology announced today a deal with QuantuMDx in support of the UK firm's development of a handheld point-of-care molecular diagnostic device.
The agreement is one of three announced by SIMTech and covers the transfer and licensing of microfluidics technology. QuantuMDx's device, which the company plans on launching in 2015, works with a patient sample that is placed into a cassette. The cassette is placed into a reader which analyzes the sample and delivers the results.
"The single-use disposable cassette is the key part of a handheld multiplex MDx device for analyzing whole blood for DNA mutation testing or for infectious disease testing," SIMTech said. "The low-cost cassette includes microfluidics handling of samples, on-chip sample preparation, polymerase chain reaction, and detection modules."
Financial and other terms of the deal were not disclosed.